These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early electrocardiographic findings and MR imaging-verified microvascular injury and myocardial infarct size. Nijveldt R, van der Vleuten PA, Hirsch A, Beek AM, Tio RA, Tijssen JG, Piek JJ, van Rossum AC, Zijlstra F. JACC Cardiovasc Imaging; 2009 Oct; 2(10):1187-94. PubMed ID: 19833308 [Abstract] [Full Text] [Related]
5. A mismatch index based on the difference between measured left ventricular ejection fraction and that estimated by infarct size at three months following reperfused acute myocardial infarction. Carlsen EA, Bang LE, Lønborg J, Ahtarovski KA, Køber L, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Wagner GS, Engstrøm T. J Electrocardiol; 2014 Oct; 47(2):191-6. PubMed ID: 24373864 [Abstract] [Full Text] [Related]
6. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis. Strauss DG, Selvester RH, Lima JA, Arheden H, Miller JM, Gerstenblith G, Marbán E, Weiss RG, Tomaselli GF, Wagner GS, Wu KC. Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427 [Abstract] [Full Text] [Related]
13. Comparison of the correlation of the Selvester QRS scoring system with cardiac contrast-enhanced magnetic resonance imaging-measured acute myocardial infarct size in patients with and without thrombolytic therapy. Rovers WC, van Boreen MC, Robinson M, Martin TN, Maynard C, Wagner GS, Gorgels AP. J Electrocardiol; 2009 Oct; 42(2):139-44. PubMed ID: 19159901 [Abstract] [Full Text] [Related]
14. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial. Patel MR, Worthley SG, Stebbins A, Dill T, Rademakers FE, Valeti US, Barsness GW, Van de Werf F, Hamm CW, Armstrong PW, Granger CB, Kim RJ. JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531 [Abstract] [Full Text] [Related]
15. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction. Izquierdo M, Ruiz-Granell R, Bonanad C, Chaustre F, Gomez C, Ferrero A, Lopez-Lereu P, Monmeneu JV, Nuñez J, Chorro FJ, Bodi V. Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195 [Abstract] [Full Text] [Related]
16. Comparison of Selvester QRS score with magnetic resonance imaging measured infarct size in patients with ST elevation myocardial infarction. Carlsen EA, Bang LE, Ahtarovski KA, Engstrøm T, Køber L, Kelbæk H, Vejlstrup N, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Wagner GS, Lønborg J. J Electrocardiol; 2012 Sep; 45(4):414-419. PubMed ID: 22554459 [Abstract] [Full Text] [Related]
17. The endocardial extent of reperfused first-time myocardial infarction is more predictive of pathologic Q waves than is infarct transmurality: a magnetic resonance imaging study. Engblom H, Carlsson MB, Hedström E, Heiberg E, Ugander M, Wagner GS, Arheden H. Clin Physiol Funct Imaging; 2007 Mar; 27(2):101-8. PubMed ID: 17309530 [Abstract] [Full Text] [Related]
18. Rapid initial reduction of hyperenhanced myocardium after reperfused first myocardial infarction suggests recovery of the peri-infarction zone: one-year follow-up by MRI. Engblom H, Hedström E, Heiberg E, Wagner GS, Pahlm O, Arheden H. Circ Cardiovasc Imaging; 2009 Jan; 2(1):47-55. PubMed ID: 19808564 [Abstract] [Full Text] [Related]